Chiesi USA, Inc. FDA Inspection Record

FEI 3006389494 · Inspections, Form 483s, warning letters and import refusals

Chiesi USA, Inc. is an FDA-inspected facility (FEI 3006389494) located in Cary, NC, US. RegDataLab tracks 9 FDA inspections and 3 compliance actions at this facility.

What FDA found at this site

Latest inspection
Aug 26, 2026: No Action Indicated (NAI)
Inspections on record
9 (1 OAI, 1 VAI, 7 NAI)
Last OAI inspection
Mar 24, 2010
Warning letters
3 listed by FDA for this FEI, latest Jun 22, 2010
Recalls as the recalling firm
4, latest Aug 19, 2026

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Aug 26, 2026No Action Indicated (NAI)No citations listed
Aug 1, 2024No Action Indicated (NAI)No citations listed
Jun 15, 2018No Action Indicated (NAI)No citations listed
Mar 6, 2015No Action Indicated (NAI)No citations listed
Mar 4, 2015No Action Indicated (NAI)No citations listed
Sep 20, 2012No Action Indicated (NAI)No citations listed
Jul 24, 2012No Action Indicated (NAI)No citations listed
Mar 24, 2010Official Action Indicated (OAI)Rejecting When Specifications Not Met (21 CFR 211.84(e))
Complaint Handling Procedure (21 CFR 211.198(a))
Procedure Deviations Recorded and Justified (21 CFR 211.100(b))
Control procedures to monitor and validate performance (21 CFR 211.110(a))
and 1 more
Apr 28, 2009Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Control procedures to monitor and validate performance (21 CFR 211.110(a))
Contamination, chemical or physical change, deterioration (21 CFR 314.81(b)(1)(ii))

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Aug 19, 2026Class IIID-0838-2026Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx…
Failed Stability Specifications: Out of specification stability result for the protein concentration profile.
Jul 6, 2026Class IID-0689-2026CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials…
Lack of Assurance of Sterility
Mar 17, 2026Class IID-0402-2026CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only…
Lack of Assurance of Sterility
May 31, 2019Class IID-1341-2019ZYFLO CR (zileuton) extended-release tablets, 600 mg, 120-count bottles, Rx only… and 1 more product
Failed Dissolution Specifications: Out of specification result for dissolution.

FDA record score

9 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

8 records behind this number
RecordDatePoints x age weightAdds
Class II recall D-0689-2026, this FEI as the recalling firmJul 6, 20264 x 14
Class II recall D-0402-2026, this FEI as the recalling firmMar 17, 20264 x 14
Class II recall D-1341-2019, this FEI as the recalling firmMay 31, 20194 x 0.251
Warning letter on FDA's dashboard, which does not show close-outsJun 22, 201010 years or older, so it adds no points0
Inspection classified OAIMar 24, 201010 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsNov 13, 200910 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsMay 4, 200910 years or older, so it adds no points0
Inspection classified VAIApr 28, 200910 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Chiesi USA, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Chiesi USA, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Chiesi USA, Inc.
Location
Cary, NC (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.